Revascularization for patients with heart failure. Inconsistencies between theory and practice

European Journal of Heart Failure

Volumn 13, Issue 7, 2011, Pages 694-697

  Cleland, John G F ^a   Freemantle, Nick ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; DRUG EFFICACY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); MORTALITY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79959963616     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr075     Document Type: Review

References (23)

1. Lu KJ, Yan BP, Ajani AE, Wilson WM, Duffy SJ, Gurvitch R, Clark DJ, Brennan A, Reid C, Andrianopoulos N, Krum H. Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: analysis of the Melbourne Interventional Group registry. Eur J Heart Fail 2011;13:416-422.
2. Torabi A, Cleland JGF, Khan NK, Loh PH, Clark AL, Alamgir F, Caplin JL, Rigby AS, Goode K. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J 2008;29:859-870. (Pubitemid 351499497)
3. Torabi A, Rigby AS, Cleland JGF. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol 2009;55:79-81.
4. The WASH study steering committee and investigators. The WASH study (Warfarin/ Aspirin Study in Heart failure): rationale, design and endpoints. Eur J Heart Fail 1999;1:95-99.
5. Cleland JGF, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA. The Warfarin/Aspirin Study in Heart Failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004;148:157-164. (Pubitemid 38900496)
6. Massie B, Collins JF, Ammon SE, Armstrong PW, Cleland JGF, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K, Warren SR, for the WATCH Trial Investigators. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The Warfarin and Antiplatelet Therapy in Chronic Heart Failure WATCH) Trial. Circulation 2009;119:1616-1624.
7. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
8. Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, Van Veldhuisen DJ, Waagstein F,Wedel H, Wikstrand J. Plasma concentration of amino-terminal probrain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol 2009;54:1850-1859.
9. Gissi-HF I, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebocontrolled trial. Lancet 2008;372:1231-1239.
10. Cleland JG, Calvert M, Freemantle N, Arrow Y, Ball SG, Bonser RS, Chattopadhyay S, Norell MS, Pennell DJ, Senior R. The Heart Failure Revascularisation Trial (HEART). Eur J Heart Fail 2011;13:227-233.
11. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607-1616.
12. Cleland JGF, Coletta AP, Freemantle N, Clark AL. Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II. Eur J Heart Fail 2011;13:805-808.
13. Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni A, Marchioli R, Nicolosi GL, Porcu M, On Behalf Of The GISSI-HF Investigators. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004;6:635-641. (Pubitemid 39070519)
14. Cleland JGF, Buga L. Defibrillators-a shocking therapy for cardiomyopathy? Nat Rev Cardiol 2010;7:69-70.
15. Cleland JGF, Massie BM, Packer M. Sudden death in heart failure: vascular or electrical? Eur J Heart Fail 1999;1:41-45. (Pubitemid 30074673)
16. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R et al. Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. The Lancet 1994;344:563-570. (Pubitemid 24267213)
17. Passamani E, Davis KB, Gillespie MJ, Killip T, and the CASS principal investigators and their associates. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. New Engl J Med 1985;312:1665-1671. (Pubitemid 15068573)
18. The Veterans Administration coronary Artery Bypass Surgery Cooperative Study Group. Eleven year survival in the veterans administration randomised trial of coronary bypass surgery for stable angina. New Engl J Med 1984;311: 1333-1339.
19. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39: 1151-1158. (Pubitemid 34267418)
20. Kunadian V, Zaman A, Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies. Eur J Heart Fail 2011;13:773-784.
21. Cleland JGF, Freemantle N, Ball SG, Bonser RS, Camici PG, Chattopadhyay S, Dutka D, Hampton J, Large S, Norell MS, Pennell DJ, Pepper J, Sanda S, Senior R, Smith D. The heart failure revascularization trial (HEART): rationale design and methodology. Eur J Heart Fail 2003;5:295-303. (Pubitemid 37011858)
22. Wikstrom BG, Lundqvist CB, Andren B, Lonnerholm S, Blomstrom P, Freemantle N, Remp T, Cleland JG. The effects of aetiology on outcome in patients treated with cardiac resynchronisation therapy in the CARE-HF trial. Eur Heart J 2009;30:782-788.
23. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, Panza AJ. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364:1617-1625.